Healthy Returns: New weight loss drug data show Eli Lilly is gaining ground
Jul 8, 2025 - 15:00

Eli Lilly, Novo Nordisk and Amgen release weight loss drug data as competition heats up in the market, while Abridge announces a $300 million funding round.